The Democratic Republic of the Congo and neighbouring countries are confronting a rapidly evolving Bundibugyo Ebola outbreak that the World Health Organization has declared a public health emergency of international concern. This article explains the outbreak’s current scope, the WHO-led response in partnership with Africa CDC and national governments, the immediate actions communities and health systems must take, and the scientific and operational pathways being pursued to stop transmission and save lives.

The scale and speed of the outbreak demand urgent attention. Official reporting shows confirmed cases concentrated in the DRC with spillover into Uganda, and a much larger number of suspected cases and deaths that indicate the epidemic is outpacing detection and response efforts. WHO’s risk assessment was recently raised to “very high” at the national level, while regional risk remains high and global risk is assessed as low; nonetheless, countries bordering the DRC are at especially high risk and must take immediate, coordinated action. These assessments are critical for searchers and decision makers who need to prioritize surveillance, cross-border coordination, and resource allocation now.

Frontline response priorities are clear and evidence-based: rapid case detection, rigorous contact tracing, safe and compassionate case management, strengthened laboratory capacity, strict infection prevention and control, and intensive risk communication and community engagement.  WHO is supporting national authorities on every pillar of the response while working with Africa CDC to establish a continental Incident Management Support Team and finalize a multi-agency Strategic Preparedness and Response Plan aligned with national strategies.  For clinicians and health administrators, this means scaling up isolation and treatment centers, ensuring personal protective equipment and training for staff, and implementing standardized protocols for triage and referral to reduce nosocomial transmission.

 The WHO Director-General emphasized that community-based interventions must be prioritized where there is a trust deficit, and that security incidents at health facilities underscore the need for culturally sensitive engagement and protection of health workers.  Search engines and social platforms are amplifying public concern; accurate, empathetic messaging that counters misinformation will improve cooperation with contact tracing and safe burial practices, which are proven to reduce transmission.

Scientific countermeasures are being fast-tracked even as operational response scales up. Unlike more common Ebola strains, Bundibugyo virus currently has no approved vaccines or therapeutics, and only two prior outbreaks have been recorded historically.  WHO has convened partners under an interim Medical Countermeasures Network to review candidate vaccines, therapeutics, and diagnostics. The organization has recommended prioritizing two monoclonal antibodies for advancement into clinical trials and is evaluating the antiviral obeldesivir as a potential post-exposure prophylaxis for high-risk contacts.  For researchers and funders, this is a call to accelerate clinical trial readiness, ethical review, and manufacturing scale-up while ensuring trials are conducted in partnership with affected countries.